Developer docs
API playgroundTry for free, no card

Search company profiles

Parker Waichman LLP - Personal Injury Accident Attorneys

Full company profile

uuid0006rlf

Namestring
Parker Waichman LLP - Personal Injury Accident Attorneys
Legal namestring
Parker Waichman LLP
Websiteurl
yourlawyer.com
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Parker Waichman LLP is a US-based personal injury law firm headquartered in Port Washington, New York, operating as a Limited Liability Partnership with 101-250 employees. The firm represents individual plaintiffs in complex personal injury matters, with particular focus on mass tort and multidistrict litigation. Its docket spans pharmaceutical product liability (GLP-1 receptor agonist drugs including Ozempic, Wegovy, Mounjaro, and Zepbound alleged to cause NAION; Paragard copper IUD breakage claims), medical device injury, nursing home neglect and abuse, child sexual abuse claims under New York's Child Victims Act, and online platform liability cases including a suit against Roblox Corporation.

The firm's core capability is legal representation built on traditional professional services rather than proprietary technology, supported by a senior attorney bench with specialized MDL expertise. Jason Goldstein, a named partner, was appointed by Judge Karen Marston as Co-Chair of the Plaintiffs' Executive Committee and Federal-State Court Liaison in MDL 3163, placing the firm in a coordinating role over the federal-state prosecution of GLP-1 NAION claims. The firm has a documented trial track record, including an upheld $5 million jury verdict with punitive damages against a Nassau County nursing home. Plaintiff acquisition is driven principally by earned media through PR Newswire press releases that explicitly recruit affected individuals, complemented by referrals and its MDL positioning.

Commercially, Parker Waichman operates on a contingency fee model typical of plaintiff-side personal injury practice, where fees are realized only upon successful resolution. Geographic reach is national despite a single primary office, with active filings in at least six states (Ohio, Massachusetts, Pennsylvania, Florida, Illinois, Tennessee). No revenue, funding, or investor data is publicly disclosed, and the firm is privately held with no identified parent company or external capital backing.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersPort Washington, United States
HQ citystring
Port Washington
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
personal injury law, mass tort litigation, product liability law, accident representation, plaintiff legal services
Industry1 code
1Personal Injury & Insurance Defense
CodeBPAHAAAMPrimaryYes
NAICS code2 codes
  • Offices of Lawyers541110
  • Legal Services5411
SIC code1 code
  • Services-Legal Services8111
Product category
Personal Injury Legal Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Legal Services - Contingency Fees
TypeProfessional Services
Description

The firm represents clients in personal injury cases, typically operating on a contingency fee basis where fees are collected only upon successful resolution or verdict. The firm seeks compensation for medical expenses, lost wages, and other damages on behalf of affected individuals.

prnewswire.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components3 values
Personnel, Marketing or Sales, Operations
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Parker Waichman LLP is a plaintiffs' law firm representing individuals in personal injury, product liability, mass tort/multidistrict litigation, medical device, pharmaceutical, and institutional abuse claims. The firm provides legal counsel, case investigation, and courtroom advocacy on a contingency fee basis for injured plaintiffs.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • $5 million jury verdict including punitive damages upheld
Product overview1 text field

Parker Waichman LLP is a personal injury law firm offering legal representation services rather than a technology product or software platform. The firm specializes in litigating mass tort cases involving pharmaceutical products (GLP-1 medications such as Ozempic and Wegovy, Paragard IUD), institutional abuse cases, nursing home neglect, and online platform liability matters. No specific branded legal service products or modules are identified in the source data.

Product and service5 records
1Personal Injury Legal Representation
CategoryPersonal Injury Law
Description

Legal representation for individuals injured in accidents, including negotiation and litigation against responsible parties on a contingency fee basis.

2Mass Tort / Multidistrict Litigation
CategoryMass Tort Litigation
Description

Representation of plaintiffs in coordinated federal MDL proceedings, including serving in lead counsel and Plaintiffs' Executive Committee roles in complex dockets.

3Product Liability Representation
CategoryProduct Liability Law
Description

Legal action against manufacturers of defective consumer products, including investigations of design, manufacturing, and warning defects.

4Pharmaceutical & Medical Device Injury Claims
CategoryPharmaceutical / Medical Device Litigation
Description

Representation of individuals harmed by prescription drugs and medical devices, including cases consolidated in MDLs.

5Institutional Abuse Representation
CategoryCivil Rights / Institutional Liability
Description

Legal representation for victims of abuse in institutional settings such as nursing homes and care facilities.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1MDL 3163 Plaintiffs' Executive Committee
Strategic tierCoreTypeOthers
Description

Jason Goldstein from Parker Waichman LLP was appointed by Judge Karen Marston as Co-Chair of the Plaintiffs' Executive Committee and Federal-State Court Liaison in MDL 3163. This leadership role coordinates prosecution of GLP-1 NAION cases across federal and state courts.

prnewswire.com
Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Plaintiff mass tort firm specializing in pharmaceutical, medical device, and personal injury MDLs. Comparable in contingency fee model, mass tort leadership roles, and national plaintiff acquisition via advertising.

TypeDirect peer
Description

National plaintiff-side mass tort and personal injury firm active in pharmaceutical MDLs and catastrophic injury litigation. Directly comparable on plaintiff-side MDL leadership roles, contingency fee model, and mass tort docket breadth.

TypeDirect peer
Description

Plaintiff-side firm handling securities, mass tort, and class action litigation. Comparable in lead counsel roles in complex MDLs and contingency fee representation of plaintiff classes.

4Onder Law Firm
TypeEmerging player
Description

Plaintiff-side mass tort firm active in pharmaceutical MDLs including GLP-1 and Paragard litigation. Comparable on emerging mass tort leadership and contingency fee plaintiff representation, though smaller in scale.

TypeDirect peer
Description

Plaintiff mass tort and personal injury firm handling pharmaceutical, medical device, and institutional abuse cases. Directly comparable on mass tort committee leadership, contingency fee revenue, and aggressive trial practice.

TypeDirect peer
Description

New York-based plaintiff personal injury and mass tort firm with active pharmaceutical and product liability MDL practice. Comparable geographic base, plaintiff-side contingency fee model, and significant pharmaceutical docket activity.

TypeDirect peer
Description

Plaintiff-side mass tort and class action firm with significant pharmaceutical and medical device MDL presence. Comparable on lead counsel appointments, scientific evidence development, and complex multidistrict litigation.

TypeDirect peer
Description

National plaintiff personal injury and mass tort firm with pharmaceutical, medical device, and class action practice. Comparable plaintiff-side model, MDL participation, and contingency fee structure.

TypeDirect peer
Description

Plaintiff-side class action and mass tort firm with deep pharmaceutical and product liability practice. Closely comparable in MDL committee leadership, contingency fee structure, and representation of individual plaintiffs against large corporate defendants.

TypeDirect peer
Description

Plaintiff mass tort firm active in pharmaceutical and consumer product MDLs including Paragard IUD litigation. Direct peer for medical device MDL work and contingency fee plaintiff representation.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Parker Waichman LLP - Personal Injury Accident Attorneys

Personal Injury Legal Servicesyourlawyer.com

What Parker Waichman LLP - Personal Injury Accident Attorneys does

Parker Waichman LLP is a US-based personal injury law firm headquartered in Port Washington, New York, operating as a Limited Liability Partnership with 101-250 employees. The firm represents individual plaintiffs in complex personal injury matters, with particular focus on mass tort and multidistrict litigation. Its docket spans pharmaceutical product liability (GLP-1 receptor agonist drugs including Ozempic, Wegovy, Mounjaro, and Zepbound alleged to cause NAION; Paragard copper IUD breakage claims), medical device injury, nursing home neglect and abuse, child sexual abuse claims under New York's Child Victims Act, and online platform liability cases including a suit against Roblox Corporation.

The firm's core capability is legal representation built on traditional professional services rather than proprietary technology, supported by a senior attorney bench with specialized MDL expertise. Jason Goldstein, a named partner, was appointed by Judge Karen Marston as Co-Chair of the Plaintiffs' Executive Committee and Federal-State Court Liaison in MDL 3163, placing the firm in a coordinating role over the federal-state prosecution of GLP-1 NAION claims. The firm has a documented trial track record, including an upheld $5 million jury verdict with punitive damages against a Nassau County nursing home. Plaintiff acquisition is driven principally by earned media through PR Newswire press releases that explicitly recruit affected individuals, complemented by referrals and its MDL positioning.

Commercially, Parker Waichman operates on a contingency fee model typical of plaintiff-side personal injury practice, where fees are realized only upon successful resolution. Geographic reach is national despite a single primary office, with active filings in at least six states (Ohio, Massachusetts, Pennsylvania, Florida, Illinois, Tennessee). No revenue, funding, or investor data is publicly disclosed, and the firm is privately held with no identified parent company or external capital backing.

Parker Waichman LLP - Personal Injury Accident Attorneys firmographics

Firmographics
Name
Parker Waichman LLP - Personal Injury Accident Attorneys
Legal name
Parker Waichman LLP
Website
https://yourlawyer.com
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
101–250 employees
Ownership category
akta.pro rank

Parker Waichman LLP - Personal Injury Accident Attorneys industry classification

Industry
Product category
Personal Injury Legal Services
NAICS
Offices of Lawyers (541110), Legal Services (5411)
SIC
Services-Legal Services (8111)
akta.pro primary industry
Personal Injury & Insurance Defense (BPAHAAAM)

Keywords

  • Personal injury law
  • Mass tort litigation
  • Product liability law
  • Accident representation
  • Plaintiff legal services

Where Parker Waichman LLP - Personal Injury Accident Attorneys is headquartered

Location

Headquarters

HQ city
Port Washington
HQ country
United States
HQ region
North America

Markets served

Parker Waichman LLP - Personal Injury Accident Attorneys business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Marketing or Sales, Operations

Revenue model

  1. Legal Services - Contingency Fees: The firm represents clients in personal injury cases, typically operating on a contingency fee basis where fees are collected only upon successful resolution or verdict. The firm seeks compensation for medical expenses, lost wages, and other damages on behalf of affected individuals.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Parker Waichman LLP - Personal Injury Accident Attorneys product offering

Product offering

Core offering

Parker Waichman LLP is a plaintiffs' law firm representing individuals in personal injury, product liability, mass tort/multidistrict litigation, medical device, pharmaceutical, and institutional abuse claims. The firm provides legal counsel, case investigation, and courtroom advocacy on a contingency fee basis for injured plaintiffs.

Product overview

Parker Waichman LLP is a personal injury law firm offering legal representation services rather than a technology product or software platform. The firm specializes in litigating mass tort cases involving pharmaceutical products (GLP-1 medications such as Ozempic and Wegovy, Paragard IUD), institutional abuse cases, nursing home neglect, and online platform liability matters. No specific branded legal service products or modules are identified in the source data.

Differentiator

Problem solved

Functional benefit

Products and services

  • Personal Injury Legal Representation Legal representation for individuals injured in accidents, including negotiation and litigation against responsible parties on a contingency fee basis.
  • Mass Tort / Multidistrict Litigation Representation of plaintiffs in coordinated federal MDL proceedings, including serving in lead counsel and Plaintiffs' Executive Committee roles in complex dockets.
  • Product Liability Representation Legal action against manufacturers of defective consumer products, including investigations of design, manufacturing, and warning defects.
  • Pharmaceutical & Medical Device Injury Claims Representation of individuals harmed by prescription drugs and medical devices, including cases consolidated in MDLs.
  • Institutional Abuse Representation Legal representation for victims of abuse in institutional settings such as nursing homes and care facilities.

Quantifiable outcome

  • $5 million jury verdict including punitive damages upheld

Companies that use Parker Waichman LLP - Personal Injury Accident Attorneys

Customer profile

Named customers9 records

Segments5 records

Ideal customer profiles1 record

Parker Waichman LLP - Personal Injury Accident Attorneys technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Parker Waichman LLP - Personal Injury Accident Attorneys partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • MDL 3163 Plaintiffs' Executive CommitteecoreOthersJason Goldstein from Parker Waichman LLP was appointed by Judge Karen Marston as Co-Chair of the Plaintiffs' Executive Committee and Federal-State Court Liaison in MDL 3163. This leadership role coordinates prosecution of GLP-1 NAION cases across federal and state courts.

Scale indicators3 records

Recent moves4 records

Expansion highlights5 records

Parker Waichman LLP - Personal Injury Accident Attorneys competitors and assessment

Company assessment

Direct peers

  • Simmons Hanly Conroy LLP: Plaintiff mass tort firm specializing in pharmaceutical, medical device, and personal injury MDLs. Comparable in contingency fee model, mass tort leadership roles, and national plaintiff acquisition via advertising.
  • Motley Rice LLC: National plaintiff-side mass tort and personal injury firm active in pharmaceutical MDLs and catastrophic injury litigation. Directly comparable on plaintiff-side MDL leadership roles, contingency fee model, and mass tort docket breadth.
  • Bernstein Litowitz Berger & Grossmann LLP: Plaintiff-side firm handling securities, mass tort, and class action litigation. Comparable in lead counsel roles in complex MDLs and contingency fee representation of plaintiff classes.
  • Levin Papantonio Rafferty LLP: Plaintiff mass tort and personal injury firm handling pharmaceutical, medical device, and institutional abuse cases. Directly comparable on mass tort committee leadership, contingency fee revenue, and aggressive trial practice.
  • Weitz & Luxenberg PC: New York-based plaintiff personal injury and mass tort firm with active pharmaceutical and product liability MDL practice. Comparable geographic base, plaintiff-side contingency fee model, and significant pharmaceutical docket activity.
  • Seeger Weiss LLP: Plaintiff-side mass tort and class action firm with significant pharmaceutical and medical device MDL presence. Comparable on lead counsel appointments, scientific evidence development, and complex multidistrict litigation.
  • Anapol Weiss: National plaintiff personal injury and mass tort firm with pharmaceutical, medical device, and class action practice. Comparable plaintiff-side model, MDL participation, and contingency fee structure.
  • Lieff Cabraser Heimann & Bernstein LLP: Plaintiff-side class action and mass tort firm with deep pharmaceutical and product liability practice. Closely comparable in MDL committee leadership, contingency fee structure, and representation of individual plaintiffs against large corporate defendants.
  • Pogust Millrood LLC: Plaintiff mass tort firm active in pharmaceutical and consumer product MDLs including Paragard IUD litigation. Direct peer for medical device MDL work and contingency fee plaintiff representation.

Emerging players

  • Onder Law Firm: Plaintiff-side mass tort firm active in pharmaceutical MDLs including GLP-1 and Paragard litigation. Comparable on emerging mass tort leadership and contingency fee plaintiff representation, though smaller in scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Parker Waichman LLP - Personal Injury Accident Attorneys social profiles

Digital presence

Parker Waichman LLP - Personal Injury Accident Attorneys financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Parker Waichman LLP - Personal Injury Accident Attorneys leadership team

Management profile

Number of profiles

Profiles1 record

Parker Waichman LLP - Personal Injury Accident Attorneys funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Parker Waichman LLP - Personal Injury Accident Attorneys M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Parker Waichman LLP - Personal Injury Accident Attorneys

What does Parker Waichman LLP - Personal Injury Accident Attorneys do?

Parker Waichman LLP is a plaintiffs' law firm representing individuals in personal injury, product liability, mass tort/multidistrict litigation, medical device, pharmaceutical, and institutional abuse claims. The firm provides legal counsel, case investigation, and courtroom advocacy on a contingency fee basis for injured plaintiffs.

Is Parker Waichman LLP - Personal Injury Accident Attorneys a public or private company?

Parker Waichman LLP - Personal Injury Accident Attorneys is a private company. It is classified as management employee owned and is currently operating.

When was Parker Waichman LLP - Personal Injury Accident Attorneys founded?

Parker Waichman LLP - Personal Injury Accident Attorneys was founded in 2022. It employs 101 to 250 people.

Where is Parker Waichman LLP - Personal Injury Accident Attorneys based?

Parker Waichman LLP - Personal Injury Accident Attorneys is headquartered in Port Washington, United States, in the North America region.

How does Parker Waichman LLP - Personal Injury Accident Attorneys make money?

One revenue line is on record: legal Services - Contingency Fees.

Who are Parker Waichman LLP - Personal Injury Accident Attorneys's main competitors?

Direct peers on record are Simmons Hanly Conroy LLP, Motley Rice LLC, Bernstein Litowitz Berger & Grossmann LLP, Levin Papantonio Rafferty LLP, Weitz & Luxenberg PC, Seeger Weiss LLP, Anapol Weiss, Lieff Cabraser Heimann & Bernstein LLP and Pogust Millrood LLC. Onder Law Firm is listed as an emerging player.

Does Parker Waichman LLP - Personal Injury Accident Attorneys have an API?

No public API is recorded for Parker Waichman LLP - Personal Injury Accident Attorneys.

What industry is Parker Waichman LLP - Personal Injury Accident Attorneys in?

Parker Waichman LLP - Personal Injury Accident Attorneys's product category is Personal Injury Legal Services. Its primary akta.pro industry code is BPAHAAAM, Personal Injury & Insurance Defense. Its NAICS code is 541110 and its SIC code is 8111.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireParker Waichman LLP Announces $8.38 Million Settlement Following Jury Selection in New York CountyParker Waichman LLP announced an $8.38 million settlement for a 43-year-old construction worker injured by falling concrete in New York City. The worker sustained lumbar and cervical spine fractures and a knee injury. The settlement was reached after jury selection and trial testimony.PR NewswireParker Waichman LLP Honors the Victims and Heroes of September 11th on the 25th AnniversaryParker Waichman LLP marked the 25th anniversary of the September 11 attacks, honoring victims and first responders. The firm highlighted New York City's release of 170,000 pages of withheld records on post-9/11 air quality and health concerns. The release renewed scrutiny of what officials knew about toxic exposure.MorningstarParker Waichman LLP Comments on Growing Public Attention Surrounding GLP-1 Vision Loss LitigationParker Waichman LLP commented on growing public attention to litigation alleging GLP-1 medications like Ozempic and Wegovy may cause NAION, a rare vision loss condition. The firm is accepting cases nationwide and offering free case reviews, while manufacturers deny the allegations and no court has found causation.PR NewswireParker Waichman LLP Files Lawsuits on behalf of Georgia and California Residents Alleging Development of Irreversible Eye Condition, NAION, after taking OzempicParker Waichman LLP filed lawsuits on behalf of a Georgia and a California resident who developed NAION after taking Ozempic. The firm cites studies linking semaglutide to a four- to sevenfold increased risk of NAION and is accepting nationwide cases for free case reviews.EIN PresswireParker Waichman LLP Expands New York Practice with Addition of Attorneys Jomarie Licata and Dominique FequiereParker Waichman LLP added attorneys Jomarie Licata and Dominique Fequiere to its New York civil litigation practice. Licata handles personal injury, motor vehicle, slip-and-fall, and construction accidents, while Fequiere focuses on medical malpractice and nursing home negligence. The expansion strengthens the firm's workflow for collecting evidence and managing complex cases.PR NewswireParker Waichman LLP Files Lawsuit on behalf of South Carolina Resident Alleging Development of Irreversible Eye Condition, NAION, after taking OzempicParker Waichman LLP filed a lawsuit on behalf of a South Carolina resident who developed NAION after taking Ozempic. The firm cites studies linking semaglutide to a four- to sevenfold increased risk of NAION and urges victims to seek free case reviews.PR NewswireParker Waichman LLP Files Lawsuit on behalf of Philadelphia Resident Alleging Development of Irreversible Eye Condition, NAION, after taking OzempicParker Waichman LLP filed a lawsuit on December 24, 2025, on behalf of a Philadelphia resident who developed NAION after taking Ozempic, a medication used for weight loss and originally developed for Type 2 diabetes. The lawsuit alleges that recent scientific studies link semaglutide, the active ingredient in Ozempic and Wegovy, to irreversible vision loss and optic nerve damage. The firm is pursuing claims nationwide and urges victims to seek legal review, criticizing Novo Nordisk for failing to provide adequate warnings.PR NewswireParker Waichman LLP Files Lawsuit on behalf of Florida Resident Alleging Development of Irreversible Eye Condition, NAION, after taking OzempicParker Waichman LLP filed a lawsuit in New Jersey state court on November 6, 2025, on behalf of a Florida resident who developed NAION (Non-Arteritic Anterior Ischemic Optic Neuropathy), an irreversible eye condition causing permanent vision loss, after taking Novo Nordisk's Ozempic. The lawsuit is one of multiple similar cases the firm has filed against Novo Nordisk, alleging the company failed to adequately warn consumers and medical professionals about the risk of permanent blindness associated with its GLP-1 medications. Research from JAMA Ophthalmology and Harvard's Mass Eye and Ear Institute found that semaglutide users face a fourfold increased risk of NAION if diabetic and a sevenfold increased risk if taking the drug for weight loss.PR NewswireParker Waichman LLP Investigates Vision Loss Cases Linked to Ozempic and Other Semaglutide Drugs Following EMA Confirmation of NAION RiskParker Waichman LLP announced it is actively handling legal claims on behalf of individuals who suffered irreversible vision loss linked to Ozempic, Wegovy, and other semaglutide medications, following the European Medicines Agency's confirmation of an increased risk of Non-Arteritic Anterior Ischaemic Optic Neuropathy (NAION). The EMA updated the product labeling for Ozempic to warn that epidemiological data indicates an elevated NAION risk during semaglutide treatment, with no identified safe time interval. The law firm has already filed multiple lawsuits and is seeking additional clients who experienced serious eye injuries after taking these GLP-1 receptor agonist drugs.PR NewswireParker Waichman LLP Files Lawsuit on behalf of Florida Resident Alleging Development of Irreversible Eye Condition, NAION, after taking OzempicParker Waichman LLP has filed multiple lawsuits in New Jersey state court against Novo Nordisk on behalf of patients who allegedly developed NAION, an irreversible eye condition causing permanent vision loss, after taking Ozempic or Wegovy. The most recent case was filed October 8, 2025, on behalf of a Florida resident who developed NAION in both eyes. Research cited in the article indicates semaglutide users face significantly elevated risk of NAION—diabetic users are four times more likely, and non-diabetic weight-loss users face a sevenfold increased risk—yet Novo Nordisk allegedly continues to fail adequate warnings on its products.